Concluding the debate around dexrazoxane

Cardiovascular toxicities from cancer treatment

The promise of immunotherapy for elderly patients

Communicating with geriatric patients

Utility and application of cancer screening in geriatrics

Treating AML in patients over 70

Benefits and drawbacks of dexrazoxane

A formulated geriatric assessment and the role of nurses

Encouraging age related reviews of three new breast cancer treatments

Screening tools in geriatric oncology

VESPA: a tool for assessing outcomes in a post operative setting

Cancer treatment related fatigue in the elderly